Paul Tudor Jones Alkermes Plc. Transaction History

Tudor Investment Corp Et Al

$25.1 Billion
Q4 2024

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Alkermes Plc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 17,120 shares of ALKS stock, worth $614,608. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,120

Holding current value

$614,608

% of portfolio

0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$25.7 - $31.46 $439,984 - $538,595	17,120 New	17,120 $492,000
Q3 2023 Nov 15, 2023	SELL	$27.17 - $31.97 $66,240 - $77,942	-2,438 Reduced 2.9%	81,774 $2.29 Million
Q2 2023 Aug 14, 2023	BUY	$28.34 - $33.63 $2.39 Million - $2.83 Million	84,212 New	84,212 $2.64 Million
Q3 2022 Nov 14, 2022	BUY	$22.0 - $31.87 $1.25 Million - $1.81 Million	56,708 Added 350.87%	72,870 $1.63 Million
Q2 2022 Aug 15, 2022	SELL	$26.4 - $30.54 $1.97 Million - $2.28 Million	-74,743 Reduced 82.22%	16,162 $481,000
Q1 2022 May 16, 2022	BUY	$23.07 - $27.99 $849,414 - $1.03 Million	36,819 Added 68.07%	90,905 $2.39 Million
Q4 2021 Feb 14, 2022	SELL	$21.47 - $32.08 $520,196 - $777,266	-24,229 Reduced 30.94%	54,086 $1.26 Million
Q3 2021 Nov 15, 2021	SELL	$23.37 - $32.13 $1.19 Million - $1.63 Million	-50,807 Reduced 39.35%	78,315 $2.42 Million
Q2 2021 Aug 16, 2021	SELL	$18.78 - $25.15 $820,930 - $1.1 Million	-43,713 Reduced 25.29%	129,122 $3.17 Million
Q1 2021 May 17, 2021	BUY	$18.21 - $23.2 $1.53 Million - $1.94 Million	83,756 Added 94.02%	172,835 $3.23 Million
Q4 2020 Feb 16, 2021	BUY	$15.39 - $22.1 $772,993 - $1.11 Million	50,227 Added 129.28%	89,079 $1.78 Million
Q3 2020 Nov 16, 2020	BUY	$16.16 - $20.66 $627,848 - $802,682	38,852 New	38,852 $644,000
Q2 2020 Aug 14, 2020	SELL	$13.31 - $19.41 $562,986 - $821,004	-42,298 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$13.06 - $21.24 $29,946 - $48,703	-2,293 Reduced 5.14%	42,298 $610,000
Q4 2019 Feb 14, 2020	BUY	$17.29 - $21.74 $105,624 - $132,809	6,109 Added 15.87%	44,591 $910,000
Q3 2019 Nov 14, 2019	SELL	$19.51 - $24.28 $2.18 Million - $2.72 Million	-111,898 Reduced 74.41%	38,482 $751,000
Q2 2019 Aug 14, 2019	BUY	$21.47 - $37.33 $3.23 Million - $5.61 Million	150,380 New	150,380 $3.39 Million
Q1 2019 May 15, 2019	SELL	$28.4 - $36.49 $1.72 Million - $2.22 Million	-60,707 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$27.94 - $44.61 $1.7 Million - $2.71 Million	60,707 New	60,707 $1.79 Million
Q2 2018 Aug 14, 2018	SELL	$40.56 - $51.36 $635,412 - $804,605	-15,666 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$53.61 - $67.26 $158,578 - $198,955	2,958 Added 23.28%	15,666 $908,000
Q4 2017 Feb 14, 2018	BUY	$47.69 - $55.39 $606,044 - $703,896	12,708	12,708 $696,000

Others Institutions Holding ALKS

# of Institutions

374

Shares Held

173M

Call Options Held

231K

Put Options Held

158K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $5.9B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account